BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27257180)

  • 1. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
    Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
    Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
    Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
    Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of
    Schmidt J; Ramis-Zaldivar JE; Nadeu F; Gonzalez-Farre B; Navarro A; Egan C; Montes-Mojarro IA; Marafioti T; Cabeçadas J; van der Walt J; Dojcinov S; Rosenwald A; Ott G; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2017 Jul; 130(3):323-327. PubMed ID: 28533310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
    Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.
    Salmeron-Villalobos J; Egan C; Borgmann V; Müller I; Gonzalez-Farre B; Ramis-Zaldivar JE; Nann D; Balagué O; López-Guerra M; Colomer D; Oschlies I; Klapper W; Glaser S; Ko YH; Bonzheim I; Siebert R; Fend F; Pittaluga S; Campo E; Salaverria I; Jaffe ES; Quintanilla-Martinez L
    Blood Adv; 2022 Aug; 6(16):4661-4674. PubMed ID: 35609565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
    Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
    Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
    Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
    Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
    Katzenberger T; Kalla J; Leich E; Stöcklein H; Hartmann E; Barnickel S; Wessendorf S; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Blood; 2009 Jan; 113(5):1053-61. PubMed ID: 18978208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
    Salaverria I; Weigert O; Quintanilla-Martinez L
    Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
    Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
    Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.
    Zamò A; Pischimarov J; Horn H; Ott G; Rosenwald A; Leich E
    Br J Haematol; 2018 Feb; 180(3):391-394. PubMed ID: 29193015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.
    Zamò A; Pischimarov J; Schlesner M; Rosenstiel P; Bomben R; Horn H; Grieb T; Nedeva T; López C; Haake A; Richter J; Trümper L; Lawerenz C; Klapper W; Möller P; Hummel M; Lenze D; Szczepanowski M; Flossbach L; Schreder M; Gattei V; Ott G; Siebert R; Rosenwald A; Leich E
    Leukemia; 2018 Mar; 32(3):685-693. PubMed ID: 28824170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of t (14; 18) chromosomal translocation in paraffin-embedded tissues of follicular lymphoma and its clinical significance].
    Zhang PH; Zhou XY; Shui RH; Zhang TM; Zheng AH; Guo XH; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):600-4. PubMed ID: 18070448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
    Raghoebier S; Broos L; Kramer MH; van Krieken JH; Kluin-Nelemans JC; van Ommen GJ; Kluin P
    Leukemia; 1995 Oct; 9(10):1748-55. PubMed ID: 7564520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
    Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.